Hostname: page-component-6898cfcb55-kwdml Total loading time: 0 Render date: 2026-11-11T20:45:09.539Z Has data issue: false hasContentIssue false

Fetal valproate syndrome with coronary arteriovenous fistula: a case report

Published online by Cambridge University Press:  18 January 2021

Alper Doğan
Affiliation:
Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkey
Ali Baykan*
Affiliation:
Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkey
Cagdas Vural
Affiliation:
Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkey
*
Author for correspondence: Dr A. Baykan, Erciyes University School of Medicine, Division of Pediatric Cardiology Kayseri, Turkey. Tel: +90 352 2453222. E-mail: alibaykan@yahoo.com
Rights & Permissions [Opens in a new window]

Abstract

Interestingly, our case presenting with coronary AV fistula firstly reported in the literature with fetal valproate syndrome. Although differential diagnosis is sometimes difficult, it can be diagnosed with detailed history, physical examination and appropriate laboratory tests. Fetal valproate syndrome can be prevented by discontinue of the valproic acid especially during first trimester of pregnancy.

Information

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press
Figure 0

Figure 1.Clinical findings of the patient.

Figure 1

Figure 2.A coronary AV fistula that draining from the left coronary artery to the right atrium (on the left). The coronary AV fistula was closed with the ADO-II AS device through the aorta (on the right).